Tofacitinib Citrate (540737-29-9)
Product Summary
Tofacitinib citrate is a Janus kinase inhibitor, trade name Xeljanz, for the treatment of methotrexate inadequate response or intolerance to severe active rheumatoid arthritis (RA) in adult patients. Product Name: Tofacitinib Citrate CAS No.: 540737-29-9 Assay: 99% Specification: CP, EP, In-house, ...
Product Custom Attributes
Tofacitinib Citrate 540737-29-9
,tofacitinib vitiligo CAS: 540737-29-9
,CAS: 540737-29-9 alopecia tofacitinib
Trading Properties
Product Description
Tofacitinib citrate is a Janus kinase inhibitor, trade name Xeljanz, for the treatment of methotrexate inadequate response or intolerance to severe active rheumatoid arthritis (RA) in adult patients.
| Product Name: | Tofacitinib Citrate |
| CAS No.: | 540737-29-9 |
| Assay: | 99% |
| Specification: | CP, EP, In-house, as required |
| Molecular Formula: | C22H28N6O8 |
| Molecular Weight: | 504.50 |
| Shelf Life: | 2 Years |
| Package: | 25kg/drum |



Contact Our Experts And Get A Free Consultation!
Our mission is to offer "High Quality" & "Good Service" & "Fast Delivery" to help our clients to gain more profits.